...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Identification and preliminary structure-activity relationship studies of novel pyridyl sulfonamides as potential Chagas disease therapeutic agents
【24h】

Identification and preliminary structure-activity relationship studies of novel pyridyl sulfonamides as potential Chagas disease therapeutic agents

机译:新型吡啶基磺胺酰胺作为潜在的Chagas疾病治疗剂的鉴定和初步结构 - 活性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Chagas disease is a neglected pathology responsible for about 12,000 deaths every year across Latin America. Although six million people are infected by the Trypanosoma cruzi, current therapeutic options are limited, highlighting the need for new drugs. Here we report the preliminary structure activity relationships of a small library of 17 novel pyridyl sulfonamide derivatives. Analogues 4 and 15 displayed significant potency against intracellular amastigotes with EC50 of 5.4 mu M and 8.6 OA. In cytotoxicity assays using mice fibroblast L929 cell lines, both compounds indicated low toxicity with decent selectivity indices (SI) 36 and 23 respectively. Hence these compounds represent good starting points for further lead optimization. (C) 2018 Elsevier Ltd. All rights reserved.
机译:Chagas病是一种忽视的病理学,在拉丁美洲每年负责约12,000人死亡。 虽然六百万人受到葡萄球菌瘤Cruzi的感染,但目前的治疗选择有限,突出了对新药的需求。 在这里,我们报告了17个新型吡啶磺酰胺衍生物的小文库的初步结构活性关系。 类似物4和15显示出与5.4 mu m和8.6 oa的EC50的细胞内amastigots显着效力。 在使用小鼠成纤维细胞L929细胞系的细胞毒性测定中,两种化合物分别表明了与体面的选择性指数(Si)& 36和> 23分别表示低毒性。 因此,这些化合物代表了进一步的铅优化的良好起点。 (c)2018年elestvier有限公司保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号